Ospedale Maggiore, Novara Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2004
NCT00320229
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

Cardiologia 2 - Emodinamica - Ospedale Maggiore, Novara, Italy | Chief Interventional Cardiology - Ospedale Maggiore - Novara - Italy

Active Ingredients

Drugs in Phase 4 Trials (1)

abciximab (Reopro) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Disease (Phase 4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1